Quadrant Capital Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Sell |
2,004
-688
| -26% | -$361K | 0.04% | 457 |
|
|
2025
Q1 | $1.71M | Buy |
2,692
+1,842
| +217% | +$1.17M | 0.06% | 233 |
|
|
2024
Q4 | $605K | Sell |
850
-167
| -16% | -$119K | 0.04% | 281 |
|
|
2024
Q3 | $1.07M | Sell |
1,017
-1
| -0.1% | -$1.05K | 0.07% | 194 |
|
|
2024
Q2 | $1.07M | Buy |
1,018
+51
| +5% | +$53.6K | 0.08% | 178 |
|
|
2024
Q1 | $931K | Buy |
967
+8
| +0.8% | +$7.7K | 0.07% | 195 |
|
|
2023
Q4 | $842K | Buy |
959
+50
| +6% | +$43.9K | 0.07% | 198 |
|
|
2023
Q3 | $748K | Sell |
909
-2
| -0.2% | -$1.65K | 0.07% | 193 |
|
|
2023
Q2 | $655K | Sell |
911
-45
| -5% | -$32.3K | 0.07% | 205 |
|
|
2023
Q1 | $786K | Buy |
956
+123
| +15% | +$101K | 0.08% | 181 |
|
|
2022
Q4 | $601K | Buy |
833
+49
| +6% | +$35.4K | 0.07% | 209 |
|
|
2022
Q3 | $540K | Buy |
784
+149
| +23% | +$103K | 0.07% | 194 |
|
|
2022
Q2 | $375K | Buy |
635
+65
| +11% | +$38.4K | 0.05% | 271 |
|
|
2022
Q1 | $398K | Buy |
570
+31
| +6% | +$21.6K | 0.05% | 273 |
|
|
2021
Q4 | $340K | Buy |
539
+28
| +5% | +$17.7K | 0.04% | 307 |
|
|
2021
Q3 | $309K | Buy |
511
+53
| +12% | +$32K | 0.04% | 285 |
|
|
2021
Q2 | $256K | Buy |
458
+24
| +6% | +$13.4K | 0.04% | 315 |
|
|
2021
Q1 | $205K | Buy |
434
+110
| +34% | +$52K | 0.03% | 347 |
|
|
2020
Q4 | $157K | Buy |
324
+14
| +5% | +$6.78K | 0.03% | 363 |
|
|
2020
Q3 | $174K | Buy |
310
+22
| +8% | +$12.3K | 0.04% | 286 |
|
|
2020
Q2 | $180K | Sell |
288
-407
| -59% | -$254K | 0.04% | 288 |
|
|
2020
Q1 | $333K | Buy |
695
+427
| +159% | +$205K | 0.06% | 273 |
|
|
2019
Q4 | $95K | Buy |
268
+234
| +688% | +$82.9K | 0.01% | 1008 |
|
|
2019
Q3 | $7K | Sell |
34
-474
| -93% | -$97.6K | ﹤0.01% | 1858 |
|
|
2019
Q2 | $154K | Buy |
508
+152
| +43% | +$46.1K | 0.02% | 675 |
|
|
2019
Q1 | $141K | Buy |
356
+248
| +230% | +$98.2K | 0.02% | 632 |
|
|
2018
Q4 | $32K | Buy |
108
+53
| +96% | +$15.7K | 0.01% | 1040 |
|
|
2018
Q3 | $19K | Buy |
55
+7
| +15% | +$2.42K | 0.01% | 1013 |
|
|
2018
Q2 | $13K | Sell |
48
-29
| -38% | -$7.85K | ﹤0.01% | 1155 |
|
|
2018
Q1 | $23K | Sell |
77
-22
| -22% | -$6.57K | 0.01% | 904 |
|
|
2017
Q4 | $30K | Buy |
99
+19
| +24% | +$5.76K | 0.01% | 778 |
|
|
2017
Q3 | $31K | Sell |
80
-16
| -17% | -$6.2K | 0.01% | 750 |
|
|
2017
Q2 | $38K | Buy |
96
+54
| +129% | +$21.4K | 0.02% | 640 |
|
|
2017
Q1 | $12K | Sell |
42
-38
| -48% | -$10.9K | 0.01% | 1012 |
|
|
2016
Q4 | $24K | Buy |
80
+8
| +11% | +$2.4K | 0.01% | 695 |
|
|
2016
Q3 | $25K | Buy |
72
+16
| +29% | +$5.56K | 0.02% | 671 |
|
|
2016
Q2 | $17K | Sell |
56
-71
| -56% | -$21.6K | 0.01% | 781 |
|
|
2016
Q1 | $41K | Buy |
127
+60
| +90% | +$19.4K | 0.03% | 444 |
|
|
2015
Q4 | $33K | Sell |
67
-60
| -47% | -$29.6K | 0.02% | 452 |
|
|
2015
Q3 | $58K | Sell |
127
-56
| -31% | -$25.6K | 0.04% | 376 |
|
|
2015
Q2 | $91K | Buy |
+183
| New | +$91K | 0.06% | 270 |
|